Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 928.79% is 123% above its 5-year average of 416.19%, near the high end of its 5-year range (28.96%–1133.36%).
As of the fiscal period ended Tuesday, June 30, 2026. 10.62% above its 12-month average of 839.59%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 928.79%.
DEBT TO ASSETS RATIO
928.79%
DEBT TO ASSETS RATIO AVG TTM
839.59%
DEBT TO ASSETS RATIO AVG 3Y
599.07%
DEBT TO ASSETS RATIO AVG 5Y
416.19%
DEBT TO ASSETS RATIO AVG 10Y
113.75%
DEBT TO ASSETS RATIO AVG 15Y
51.91%
DEBT TO ASSETS RATIO AVG 20Y
15.77%
CURRENT VS TTM AVG
+10.62%
CURRENT VS 3Y AVG
+55.04%
CURRENT VS 5Y AVG
+123.16%
CURRENT VS 10Y AVG
+716.51%
CURRENT VS 15Y AVG
+1689.34%
CURRENT VS 20Y AVG
+5789.56%
SECTOR MEDIAN · HEALTHCARE
0.11%
median of 532 covered companies
CURRENT VS SECTOR MEDIAN
+884459.30%
vs the sector median at left
Galectin Therapeutics Inc.
Market Cap
$237.08M
Debt to Assets Ratio
928.79%
TTM Avg
839.59%
3Y Avg
599.07%
5Y Avg
416.19%
Market Cap
$241.60M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$238.86M
Debt to Assets Ratio
0.15%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$244.19M
Debt to Assets Ratio
0.68%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Galectin Therapeutics Inc. (GALT) | $237.08M | 928.79% | 839.59% | 599.07% | 416.19% |
| High Tide Inc. (HITI)vs › | $241.20M | 0.33% | N/A | N/A | N/A |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $241.60M | 0.03% | N/A | N/A | N/A |
| Biodesix, Inc. (BDSX)vs › | $239.67M | 0.75% | N/A | N/A | N/A |
| Akebia Therapeutics, Inc. (AKBA)vs › | $238.86M | 0.15% | N/A | N/A | N/A |
| Lifecore Biomedical, Inc. (LFCR)vs › | $244.19M | 0.68% | N/A | N/A | N/A |
| InflaRx N.V. (IFRX)vs › | $244.51M | 0.00% | N/A | N/A | N/A |
| Invivyd, Inc. (IVVD)vs › | $245.85M | 0.04% | N/A | N/A | N/A |
| BioAge Labs Inc. (BIOA)vs › | $235.69M | 0.01% | N/A | N/A | N/A |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $246.30M | 0.00% | N/A | N/A | N/A |
Debt/Assets
928.8%
Debt/Equity
N/A
Current Ratio
0.10
Interest Coverage
-2.7x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 928.79% |
| 2026-03-31 | 861.20% |
| 2025-12-31 | 684.81% |
| 2025-09-30 | 950.73% |
| 2025-06-30 | 772.40% |
| 2025-03-31 | 1133.36% |
| 2024-12-31 | 607.29% |
| 2024-09-30 | 360.99% |
| 2024-06-30 | 337.97% |
| 2024-03-31 | 318.73% |
| 2023-12-31 | 254.63% |
| 2023-09-30 | 276.21% |
| 2023-06-30 | 300.79% |
| 2023-03-31 | 247.41% |
| 2022-12-31 | 187.31% |
| 2022-09-30 | 166.63% |
| 2022-06-30 | 114.42% |
| 2022-03-31 | 87.13% |
| 2021-12-31 | 69.47% |
| 2021-09-30 | 50.79% |
| 2021-06-30 | 28.96% |
| 2021-03-31 | 0.18% |
| 2020-12-31 | 0.15% |
| 2020-09-30 | 0.18% |
| 2020-06-30 | 0.17% |
| 2020-03-31 | 0.18% |
| 2019-12-31 | 0.08% |
| 2019-09-30 | 0.07% |
| 2019-06-30 | 0.07% |
| 2019-03-31 | 0.43% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 28.41% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 16.34% |
| 2007-06-30 | 14.56% |
| 2007-03-31 | 12.21% |
| 2006-12-31 | 80.78% |
| 2006-09-30 | 86.91% |
| 2006-06-30 | 111.16% |
| 2006-03-31 | 119.74% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 0.00% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | 0.00% |
| 2003-12-31 | 0.00% |
| 2003-09-30 | 0.00% |
| 2003-06-30 | 0.00% |
| 2003-03-31 | 0.58% |
| 2002-12-31 | 0.66% |
| 2002-09-30 | 7.20% |
